Inhibición dual de la neprilisina y el receptor de angiotensina II: nueva estrategia prometedora en el tratamiento de la enfermedad cardiovascular
Dual inhibition of neprilysin and angiotensin II receptor: promising new strategy in the treatment of cardiovascular disease
Leído
17617
Vecesse ha leído el artículo
14294
Total PDF
3323
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 16 | 4 | 20 |
| 2025 11 | 53 | 36 | 89 |
| 2025 10 | 41 | 25 | 66 |
| 2025 9 | 44 | 29 | 73 |
| 2025 8 | 36 | 20 | 56 |
| 2025 7 | 49 | 10 | 59 |
| 2025 6 | 38 | 10 | 48 |
| 2025 5 | 74 | 14 | 88 |
| 2025 4 | 72 | 8 | 80 |
| 2025 3 | 51 | 14 | 65 |
| 2025 2 | 35 | 9 | 44 |
| 2025 1 | 26 | 14 | 40 |
| 2024 12 | 25 | 9 | 34 |
| 2024 11 | 27 | 13 | 40 |
| 2024 10 | 43 | 24 | 67 |
| 2024 9 | 45 | 11 | 56 |
| 2024 8 | 23 | 6 | 29 |
| 2024 7 | 21 | 9 | 30 |
| 2024 6 | 27 | 24 | 51 |
| 2024 5 | 28 | 12 | 40 |
| 2024 4 | 45 | 23 | 68 |
| 2024 3 | 37 | 18 | 55 |
| 2024 2 | 41 | 14 | 55 |
| 2024 1 | 49 | 7 | 56 |
| 2023 12 | 33 | 22 | 55 |
| 2023 11 | 20 | 13 | 33 |
| 2023 10 | 20 | 11 | 31 |
| 2023 9 | 10 | 8 | 18 |
| 2023 8 | 12 | 8 | 20 |
| 2023 7 | 9 | 23 | 32 |
| 2023 6 | 23 | 32 | 55 |
| 2023 5 | 7 | 9 | 16 |
| 2023 4 | 16 | 5 | 21 |
| 2023 3 | 27 | 8 | 35 |
| 2023 2 | 10 | 11 | 21 |
| 2022 1 | 10 | 7 | 17 |
| 2022 12 | 24 | 13 | 37 |
| 2022 11 | 46 | 10 | 56 |
| 2022 10 | 65 | 14 | 79 |
| 2022 9 | 9 | 7 | 16 |
| 2022 8 | 17 | 11 | 28 |
| 2022 7 | 9 | 5 | 14 |
| 2022 6 | 14 | 15 | 29 |
| 2022 5 | 18 | 6 | 24 |
| 2022 4 | 12 | 9 | 21 |
| 2022 3 | 21 | 9 | 30 |
| 2022 2 | 44 | 8 | 52 |
| 2021 1 | 59 | 6 | 65 |
| 2021 12 | 39 | 21 | 60 |
| 2021 11 | 31 | 12 | 43 |
| 2021 10 | 44 | 27 | 71 |
| 2021 9 | 43 | 13 | 56 |
| 2021 8 | 34 | 10 | 44 |
| 2021 7 | 61 | 11 | 72 |
| 2021 6 | 37 | 31 | 68 |
| 2021 5 | 29 | 17 | 46 |
| 2021 4 | 90 | 41 | 131 |
| 2021 3 | 35 | 24 | 59 |
| 2021 2 | 34 | 17 | 51 |
| 2020 1 | 26 | 19 | 45 |
| 2020 12 | 32 | 16 | 48 |
| 2020 11 | 36 | 24 | 60 |
| 2020 10 | 41 | 16 | 57 |
| 2020 9 | 18 | 18 | 36 |
| 2020 8 | 24 | 19 | 43 |
| 2020 7 | 19 | 5 | 24 |
| 2020 6 | 11 | 9 | 20 |
| 2020 5 | 18 | 12 | 30 |
| 2020 4 | 16 | 5 | 21 |
| 2020 3 | 21 | 9 | 30 |
| 2020 2 | 19 | 18 | 37 |
| 2020 1 | 23 | 23 | 46 |
| 2019 12 | 22 | 31 | 53 |
| 2019 11 | 30 | 19 | 49 |
| 2019 10 | 22 | 21 | 43 |
| 2019 9 | 19 | 36 | 55 |
| 2019 8 | 11 | 11 | 22 |
| 2019 7 | 9 | 37 | 46 |
| 2019 6 | 45 | 104 | 149 |
| 2019 5 | 101 | 279 | 380 |
| 2019 4 | 50 | 192 | 242 |
| 2019 3 | 11 | 93 | 104 |
| 2019 2 | 10 | 75 | 85 |
| 2019 1 | 10 | 56 | 66 |
| 2018 12 | 15 | 74 | 89 |
| 2018 11 | 14 | 115 | 129 |
| 2018 10 | 14 | 40 | 54 |
| 2018 9 | 18 | 88 | 106 |
| 2018 8 | 7 | 215 | 222 |
| 2018 7 | 4 | 192 | 196 |
| 2018 6 | 2 | 240 | 242 |
| 2018 5 | 3 | 271 | 274 |
| 2018 4 | 5 | 314 | 319 |
| 2018 3 | 3 | 266 | 269 |
| 2018 2 | 2 | 226 | 228 |
| 2018 1 | 5 | 223 | 228 |
| 2017 12 | 3 | 182 | 185 |
| 2017 11 | 11 | 278 | 289 |
| 2017 10 | 5 | 286 | 291 |
| 2017 9 | 21 | 335 | 356 |
| 2017 8 | 2 | 278 | 280 |
| 2017 7 | 11 | 359 | 370 |
| 2017 6 | 16 | 374 | 390 |
| 2017 5 | 15 | 472 | 487 |
| 2017 4 | 23 | 412 | 435 |
| 2017 3 | 12 | 569 | 581 |
| 2017 2 | 14 | 583 | 597 |
| 2016 1 | 11 | 403 | 414 |
| 2016 12 | 26 | 310 | 336 |
| 2016 11 | 35 | 489 | 524 |
| 2016 10 | 40 | 568 | 608 |
| 2016 9 | 37 | 777 | 814 |
| 2016 8 | 35 | 579 | 614 |
| 2016 7 | 42 | 196 | 238 |
| 2016 6 | 21 | 564 | 585 |
| 2016 5 | 23 | 421 | 444 |
| 2016 4 | 24 | 246 | 270 |
| 2016 3 | 14 | 213 | 227 |
| 2016 2 | 12 | 200 | 212 |
| 2015 1 | 19 | 124 | 143 |
| 2015 12 | 9 | 85 | 94 |
| 2015 11 | 24 | 131 | 155 |
| 2015 10 | 15 | 139 | 154 |
| 2015 9 | 16 | 99 | 115 |
| 2015 8 | 11 | 88 | 99 |
| 2015 7 | 8 | 93 | 101 |
| 2015 6 | 9 | 54 | 63 |
| 2015 5 | 7 | 47 | 54 |
| 2015 4 | 7 | 42 | 49 |
| 2015 3 | 13 | 8 | 21 |
| 2015 2 | 10 | 3 | 13 |
| 2015 1 | 5 | 5 | 10 |
| 2014 12 | 3 | 4 | 7 |
| 2014 11 | 7 | 3 | 10 |
| 2014 10 | 10 | 3 | 13 |
| 2014 9 | 1 | 2 | 3 |
| 2014 8 | 2 | 2 | 4 |
Mostrar todo